StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Primary Care Portfolio Total [legacy pre-Q1 2026 by Year

Primary Care Portfolio Total [legacy pre-Q1 2026 realignment, through Q4 2025] ($M) ($M)

Pfizer Primary Care Portfolio Total [legacy pre-Q1 2026: $26,820M in FY2025, down 11.0% from a year earlier.

Latest, FY2025
26,820
Period ended Dec 31, 2025
Change on a year earlier
-11.0%
30,135 in FY2024
History
6 years
Since FY2020
Sources
5
Documents cited below

Where the FY2025 figure comes from

“|| Primary Care | $ | 26,820 | $ | 30,135 | (11%) | (12%) | $ | 15,898 | $ | 18,783 | (15%) | $ | 10,921 | $ | 11,352 | (4%) | (5%)”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗

In Q1 2026, Pfizer carved Global Hospital & Biosimilars out of Primary Care & Specialty Care into a 4th category without restating Q4 2025.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up primary Care Portfolio Total [legacy pre-Q1 2026

Cite this data

StockData. (2026). Pfizer Primary Care Portfolio Total [legacy pre-Q1 2026 ($M), annual FY2020–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/port-leg-pc-ww

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.